Main navigation
- Home
- About us
- Medicines
- Research
- Careers
- Responsibility
- Strategy and vision
- Patient safety
- Product counterfeiting
- Human rights
- Access to medicines
- In the developing world
- Sales & marketing ethics
- Research ethics
- Animal research
- Clinical trials
- Our employees
- Community support
- Climate change
- Sustainable production
- Pharmaceuticals in the environment
- Responsible procurement
- Management & measurement
- Code, policies & standards
- Reporting performance
- Partnering
- Media
- Investors
You are here
- Home
Responsibility
Our reputation is built on the trust and confidence of all our stakeholders and is one of AstraZeneca's most valuable assets
-
Strategy & vision collapse
Our core values collapse
- Integrity and high ethical standards
- Respect for the individual and diversity
- Openness, honesty, trust and support for each other
- Leadership by example at all levels
-
Combining resources in the fight against malaria
In June 2010, AstraZeneca and Medicines for Malaria Venture announced a collaboration focused on identifying novel candidate drugs for the treatment of malaria. Read the full press release
Not signed in
Page tools
Share price
- London
-
32.38 GBP - New York
-
50.44 USD - Stockholm
-
368.30 SEK
At 01-Aug-2010 06:54 GMT
Detailed share price-
PDF basket collapse
Use your basket to collect pages in PDF format which can then be viewed as a single PDF.
